Fraunhofer-Gesellschaft

A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but also solid tumors such as ovarian and breast cancer. Fraunhofer researchers teamed up with the University Hospital of Würzburg to streamline the complicated process of manufacturing these therapies as well. This could make them much more available.

The Fraunhofer Institute for Photonic Microsystems IPMS and the Max Planck Institute of Quantum Optics (MPQ) have achieved groundbreaking results in generating arbitrary light distributions. These findings are also relevant to atomic quantum computing. Spatial light modulators can be used to hold a large number of atoms in desired positions at the same time via laser beam. Localized in this way, they become switchable information carriers for quantum computers or for other applications in quantum metrology and quantum simulation, marking a major stride toward scalable quantum systems.

People being monitored for chronic kidney disease or heart failure often have high levels of potassium in their blood (hyperkalemia) due to impaired renal potassium excretion caused by kidney damage or by medications. But such medications interfere with urinary potassium excretion. This electrolyte imbalance can be life-threatening and thus must be closely monitored. In collaboration with French start-up Ki'tech, researchers at the Fraunhofer Institute for Microengineering and Microsystems IMM want to revolutionize patient monitoring with a minimally invasive solution that measures biomarkers, including potassium, in the subcutaneous interstitial fluid.

Researchers at the Fraunhofer Institute of Optronics, System Technologies and Image Exploitation IOSB have developed a technology that uses AI to automatically log and analyze human movements inside vehicles. Their innovation, called the AktiMeter, is ideal for market research, user-centered product development and ergonomic studies.